Related Experiment Video
Updated: May 27, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Adjunctive thrombectomy in primary percutaneous intervention for acute myocardial infarction
François-Pierre Mongeon1, Otávio Rizzi Coelho-Filho, Otávio Rizzi Coelho
1Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA. francois.pierrre.mongeon@umontreal.ca
Insights
Adjunctive thrombectomy in primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction shows variable results. While early clinical outcomes may not improve, later benefits are emerging, particularly with simple aspiration catheters.
Area of Science:
- Interventional Cardiology
- Cardiovascular Medicine
- Biomedical Engineering
Background:
- Primary percutaneous coronary intervention (PCI) is standard for ST-elevation myocardial infarction (STEMI).
- Intracoronary thrombus is linked to poorer outcomes like no-reflow and stent thrombosis post-PCI.
- Adjunctive thrombectomy aims to remove thrombus before distal embolization.
Purpose of the Study:
- To review and provide perspective on trials and meta-analyses of adjunctive thrombectomy in acute myocardial infarction.
- To discuss the evolving role and late-emerging benefits of thrombectomy.
- To identify targets for future research in this field.
Main Methods:
- Review of randomized controlled trials (RCTs) and meta-analyses on adjunctive thrombectomy in primary PCI.
- Analysis of variability in devices, procedures, and outcomes across studies.
- Examination of clinical and angiographic predictors of thrombectomy benefit.
Main Results:
- Substantial variability exists in RCTs regarding devices, procedures, and outcomes.
- Improvements in myocardial perfusion endpoints often do not translate to immediate clinical outcome reductions.
- Some trials with longer follow-up report late clinical benefits after the index myocardial infarction.
Conclusions:
- Simple aspiration catheters may offer better outcomes than devices that fragment thrombus.
- Predictors for thrombectomy benefit require further definition.
- Further research is needed to optimize thrombectomy strategies in acute myocardial infarction.
Abstract:
Primary percutaneous coronary intervention (PCI) has become the favored reperfusion strategy in acute ST-segment elevation myocardial infarction. Lower post-PCI myocardial perfusion grade, no-reflow and even drug-eluting stent thrombosis have been related to the presence of intracoronary thrombus. Adjunctive thrombectomy refers to procedures and devices that remove thrombotic material from the infarction-related artery, in theory, before distal embolization can occur. There is substantial variability between randomized controlled trials of thrombectomy in primary PCI with regards to tested devices, procedural characteristics, adjuvant medical regimen and examined outcomes. As a general statement, improvements in myocardial perfusion endpoints do not translate into reductions in clinical outcomes. Yet, an increasing number of trials with a longer follow-up reported benefits arising late after the index myocardial infarction. Simple aspiration catheters may also produce better outcomes than devices that fragment the thrombus before aspirating debris. Clinical or angiographic variables which best predict benefits from the use of thrombectomy remain to be defined. The aim of this review is to provide perspective on the conclusions of available trials and meta-analysis of adjunctive thrombectomy in acute myocardial infarction. Targets for future studies are discussed.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
